Magnetic resonance enterography in Crohn's disease: Optimal use in clinical practice and clinical trials

Scandinavian Journal of Gastroenterology

Volumn 50, Issue 1, 2014, Pages 66-73

  Rimola, Jordi ^a   Panés, Julián ^a   Ordás, Ingrid ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Crohn's disease; Endoscopy; Magnetic resonance enterography; Management

Indexed keywords

GASTROINTESTINAL AGENT;

COMPLICATION; CROHN DISEASE; DISEASE COURSE; DRUG MONITORING; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SEVERITY OF ILLNESS INDEX;

CROHN DISEASE; DISEASE PROGRESSION; DRUG MONITORING; GASTROINTESTINAL AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; SEVERITY OF ILLNESS INDEX;

EID: 84919416684     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.968862     Document Type: Review

References (45)

1. Panes J, Bouhnik Y, Reinisch W, Stoker J, Taylor SA, Baumgart DC, et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 2013;7: 556-85.
2. Panes J, Bouzas R, Chaparro M, Garcia-Sanchez V, Gisbert JP, Martinez de Guerenu B, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther 2011;34:125-45.
3. Ordas I, Rimola J, Rodriguez S, Paredes JM, Martinez-Perez MJ, Blanc E, et al. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease. Gastroenterology 2014;146:374-82; e1.
4. Van Assche G, Herrmann KA, Louis E, Everett SM, Colombel JF, Rahier JF, et al. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease. J Crohns Colitis 2013;7:950-7.
5. Pariente B, Cosnes J, Danese S, Sandborn WJ, Lewin M, Fletcher JG, et al. Development of the Crohn's disease digestive damage score, the Lemann score. Inflamm Bowel Dis 2011;17:1415-22.
6. Desmond AN, O'Regan K, Curran C, McWilliams S, Fitzgerald T, Maher MM, et al. Crohn's disease: factors associated with exposure to high levels of diagnostic radiation. Gut 2008;57:1524-9.
7. Sinha R, Verma R, Verma S, Rajesh A. MR enterography of Crohn disease: part 1, rationale, technique, and pitfalls. AJR Am J Roentgenol 2011;197:76-9.
8. Santillan CS. MR imaging techniques of the bowel. Magn Reson Imaging Clin N Am 2014;22:1-11.
9. Rimola J, Rodriguez S, Garcia-Bosch O, Ricart E, Pages M, Pellise M, et al. Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease. Radiographics 2009;29:701-19.
10. Rimola J, Sandborn WJ, Higgins P, Coimbra A, Lu T, Rutgeerts PA, et al. Feasibility, precision and reproducibility of MR enterography for detection of inflammation in Crohn's disease in a multicenter clinical trial. Gastroenterology 2014; 146:S-174.
11. Fiorino G, Bonifacio C, Padrenostro M, Sposta FM, Spinelli A, Malesci A, et al. Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn's disease. Dig Dis Sci 2013;58:3246-55.
12. Oussalah A, Laurent V, Bruot O, Bressenot A, Bigard MA, Regent D, et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 2010;59:1056-65.
13. Punwani S, Rodriguez-Justo M, Bainbridge A, Greenhalgh R, De Vita E, Bloom S, et al. Mural inflammation in Crohn disease:location-matched histologicvalidationofMRimaging features. Radiology 2009;252:712-20.
14. Rimola J, Ordas I, Rodriguez S, Garcia-Bosch O, Aceituno M, Llach J, et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011;17: 1759-68.
15. Rimola J, Rodriguez S, Garcia-Bosch O, Ordas I, Ayala E, Aceituno M, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 2009;58:1113-20.
16. Hordonneau C, Buisson A, Scanzi J, Goutorbe F, Pereira B, Borderon C, et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease: validation of quantitative index of activity. Am J Gastroenterol 2014; 109:89-98.
17. Albert JG, Martiny F, Krummenerl A, Stock K, Lesske J, Gobel CM, et al. Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis. Gut 2005;54:1721-7.
18. Bocker U, Dinter D, Litterer C, Hummel F, Knebel P, Franke A, et al. Comparison of magnetic resonance imaging and video capsule enteroscopy in diagnosing small-bowel pathology: localization-dependent diagnostic yield. Scand J Gastroenterol 2010;45:490-500.
19. Jensen MD, Nathan T, Rafaelsen SR, Kjeldsen J. Diagnostic accuracy of capsule endoscopy for small bowel Crohn's disease is superior to that of MR enterography or CT enter-ography. Clin Gastroenterol Hepatol 2011;9:124-9.
20. Nguyen DL, Sandborn WJ, Loftus EV Jr, Larson DW, Fletcher JG, Becker B, et al. Similar outcomes of surgical and medical treatment of intra-abdominal abscesses in patients with Crohn's disease. Clin Gastroenterol Hepatol 2012;10:400-4.
21. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001;49:777-82.
22. Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology 2010;139:1147-55.
23. Hassan C, Zullo A, De Francesco V, Ierardi E, Giustini M, Pitidis A, et al. Systematic review: endoscopic dilatation in Crohn's disease. Aliment Pharmacol Ther 2007;26:1457-64.
24. Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 2008; 247:64-79.
25. Tielbeek JA, Ziech ML, Li Z, Lavini C, Bipat S, Bemelman WA, et al. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn's disease assessment with histopathology of surgical specimens. Eur Radiol 2014;24:619-29.
26. Zappa M, Stefanescu C, Cazals-Hatem D, Bretagnol F, Deschamps L, Attar A, et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis 2011;17: 984-93.
27. Rimola J, Aceituno M, Ordás I, Jáuregui A, Gallego M, Rodríguez S, et al. MRI is a valuable tool for identification of fibrosis in patients with Crohn's disease. Gastroenterology 2012;142:S22-S3.
28. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010;105:289-97.
29. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99: 956-63.
30. Bruining DH, Siddiki HA, Fletcher JG, Tremaine WJ, Sandborn WJ, Loftus EV Jr. Prevalence of penetrating disease and extraintestinal manifestations of Crohn's disease detected with CT enterography. Inflamm Bowel Dis 2008; 14:1701-6.
31. Messaris E, Chandolias N, Grand D, Pricolo V. Role of magnetic resonance enterography in the management of Crohn disease. Arch Surg 2010;145:471-5.
32. Hafeez R, Punwani S, Boulos P, Bloom S, McCartney S, Halligan S, et al. Diagnostic and therapeutic impact of MR enterography in Crohn's disease. Clin Radiol 2011; 66:1148-58.
33. García Bosch O, Ordás I, Rodríguez S, Ramírez AM, Aceituno M, Ricart E, et al. Comparison of the impact of MRI and colonoscopy on management of Crohn's disease. Gastroenterology 2012;142:S21-S2.
34. Modigliani R, Mary JY, Simon JF, Cortot A, Soule JC, Gendre JP, et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 1990;98:811-18.
35. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, et al. Infliximab, azathio-prine, or combination therapy for Crohn's disease. N Engl J Med 2010;362:1383-95.
36. Froslie KF, Jahnsen J, Moum BA, Vatn MH. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007;133:412-22.
37. Baert F, Moortgat L, Van Assche G, Caenepeel P, Vergauwe P, De Vos M, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 2010;138:463-8; quiz e10-1.
38. Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis 2009;15:1295-301.
39. Peyrin-Biroulet L, Cieza A, Sandborn WJ, Coenen M, Chowers Y, Hibi T, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 2012;61:241-7.
40. Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Lofberg R, Modigliani R, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002;122: 512-30.
41. Yacoub JH, Oto A. New magnetic resonance imaging modalities for Crohn disease. Magn Reson Imaging Clin N Am 2014;22:35-50.
42. Ream JM, Dillman JR, Adler J, Khalatbari S, McHugh JB, Strouse PJ, et al. MRI diffusion-weighted imaging (DWI) in pediatric small bowel Crohn disease: correlation with MRI findings of active bowel wall inflammation. Pediatr Radiol 2013;43:1077-85.
43. Adler J, Swanson SD, Schmiedlin-Ren P, Higgins PD, Golembeski CP, Polydorides AD, et al. Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology 2011;259:127-35.
44. Froehlich JM, Waldherr C, Stoupis C, Erturk SM, Patak MA. MR motility imaging in Crohn's disease improves lesion detection compared with standard MR imaging. Eur Radiol 2010;20:1945-51.
45. Menys A, Atkinson D, Odille F, Ahmed A, Novelli M, Rodriguez-Justo M, et al. Quantified terminal ileal motility during MR enterography as a potential biomarker of Crohn's disease activity: a preliminary study. Eur Radiol 2012;22: 2494-501.